Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Vuilleumier

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Current Drug Targets|November 28, 2014
Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathiesNathalie Satta, Nicolas Vuilleumier
World Journal of Cardiology|June 20, 2014
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunityNicolas Vuilleumier, Fabrizio Montecucco, Oliver Hartley
Clinical Biochemistry|December 2, 2019
Emerging biomarkers for cardiac arrhythmiasAngelika Hammerer-Lercher, Mehdi Namdar, Nicolas Vuilleumier
Journal of Clinical Microbiology|June 23, 2021
Performance of Fully Automated Antimicrobial Disk Diffusion Susceptibility Testing Using Copan WASP Colibri Coupled to the Radian In-Line Carousel and Expert SystemAbdessalam Cherkaoui, Gesuele Renzi, Nicolas Vuilleumier, et al.
Current Medicinal Chemistry|September 24, 2014
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseasesFederico Carbone, François Mach, Nicolas Vuilleumier, et al.
World Journal of Cardiology|June 20, 2014
Potential pathophysiological role for the vitamin D deficiency in essential hypertensionFederico Carbone, François Mach, Nicolas Vuilleumier, et al.
Current Pharmaceutical Design|September 1, 2019
Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?Nathalie Satta, Miguel A Frias, Nicolas Vuilleumier, et al.
Revue Medicale Suisse|November 17, 2009
[Cardiac biomarkers and pulmonary embolism: prognostic stratification]Grégoire Blaudszun, Nicolas Vuilleumier, Marc Righini, et al.
European Journal of Clinical Investigation|June 16, 2025
Autoimmunity in MASLD: Focus on autoantibodies, anti-apolipoprotein A1 IgG and G protein-coupled receptorsSabrina Pagano, Emmanuel Somm, François R Jornayvaz, et al.
Proteomics. Clinical Applications|December 20, 2014
Biomarkers for cardiovascular risk assessment in autoimmune diseasesPriscila Camillo Teixeira, Philippe Ferber, Nicolas Vuilleumier, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Current Drug Targets|November 28, 2014
Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathiesNathalie Satta, Nicolas Vuilleumier
World Journal of Cardiology|June 20, 2014
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunityNicolas Vuilleumier, Fabrizio Montecucco, Oliver Hartley
Clinical Biochemistry|December 2, 2019
Emerging biomarkers for cardiac arrhythmiasAngelika Hammerer-Lercher, Mehdi Namdar, Nicolas Vuilleumier
Journal of Clinical Microbiology|June 23, 2021
Performance of Fully Automated Antimicrobial Disk Diffusion Susceptibility Testing Using Copan WASP Colibri Coupled to the Radian In-Line Carousel and Expert SystemAbdessalam Cherkaoui, Gesuele Renzi, Nicolas Vuilleumier, et al.
Current Medicinal Chemistry|September 24, 2014
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseasesFederico Carbone, François Mach, Nicolas Vuilleumier, et al.
World Journal of Cardiology|June 20, 2014
Potential pathophysiological role for the vitamin D deficiency in essential hypertensionFederico Carbone, François Mach, Nicolas Vuilleumier, et al.
Current Pharmaceutical Design|September 1, 2019
Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?Nathalie Satta, Miguel A Frias, Nicolas Vuilleumier, et al.
Revue Medicale Suisse|November 17, 2009
[Cardiac biomarkers and pulmonary embolism: prognostic stratification]Grégoire Blaudszun, Nicolas Vuilleumier, Marc Righini, et al.
European Journal of Clinical Investigation|June 16, 2025
Autoimmunity in MASLD: Focus on autoantibodies, anti-apolipoprotein A1 IgG and G protein-coupled receptorsSabrina Pagano, Emmanuel Somm, François R Jornayvaz, et al.
Proteomics. Clinical Applications|December 20, 2014
Biomarkers for cardiovascular risk assessment in autoimmune diseasesPriscila Camillo Teixeira, Philippe Ferber, Nicolas Vuilleumier, et al.
Pageof 17